Latest filing published 14 Mar 2023 for Algernon Pharmaceuticals Inc..
No signal scores available.
All filings by Mark Williams on record concern Algernon Pharmaceuticals Inc. The record holds 5 filings, for trades running from 22 October 2018 to 13 March 2023.
Purchases make up the whole of the open-market record (1 purchase, €887). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 option exercises.
The record was last updated on 14 March 2023 with a transaction in Algernon Pharmaceuticals Inc. The last purchase on record was published on 14 April 2022, which is 1,657 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 2 days. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations